A guide to cell death pathways.

Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).

doi: 10.1016/S0092-8674(00)81683-9 pubmed: 10647931

Yuan, J., Lipinski, M. & Degterev, A. Diversity in the mechanisms of neuronal cell death. Neuron 40, 401–413 (2003).

doi: 10.1016/S0896-6273(03)00601-9 pubmed: 14556717

Lockshin, R. A. & Williams, C. M. Programmed cell death–I. Cytology of degeneration in the intersegmental muscles of the pernyi silkmoth. J. Insect Physiol. 11, 123–133 (1965).

doi: 10.1016/0022-1910(65)90099-5 pubmed: 14287218

Lockshin, R. A. Programmed cell death 50 (and beyond). Cell Death Differ. 23, 10–17 (2016).

doi: 10.1038/cdd.2015.126 pubmed: 26564398

Choi, D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623–634 (1988).

doi: 10.1016/0896-6273(88)90162-6 pubmed: 2908446

Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072 (2012).

pmcid: 3367386 doi: 10.1016/j.cell.2012.03.042 pubmed: 22632970

Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401–2421 (2022).

pmcid: 9273022 doi: 10.1016/j.cell.2022.06.003 pubmed: 35803244

Aits, S. & Jaattela, M. Lysosomal cell death at a glance. J. Cell Sci. 126, 1905–1912 (2013).

doi: 10.1242/jcs.091181 pubmed: 23720375

Overholtzer, M. et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131, 966–979 (2007).

doi: 10.1016/j.cell.2007.10.040 pubmed: 18045538

Frisch, S. M. & Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619–626 (1994).

doi: 10.1083/jcb.124.4.619 pubmed: 8106557

Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440–442 (1988).

doi: 10.1038/335440a0 pubmed: 3262202

Kelekar, A. & Thompson, C. B. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8, 324–330 (1998).

doi: 10.1016/S0962-8924(98)01321-X pubmed: 9704409

Cory, S. & Adams, J. M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2, 647–656 (2002).

doi: 10.1038/nrc883 pubmed: 12209154

Green, D. R. The mitochondrial pathway of apoptosis part II: the BCL-2 protein family. Cold Spring Harb. Perspect. Biol. 14, a041046 (2022).

doi: 10.1101/cshperspect.a041046 pubmed: 35701220

Motoyama, N. et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267, 1506–1510 (1995).

doi: 10.1126/science.7878471 pubmed: 7878471

Rinkenberger, J. L., Horning, S., Klocke, B., Roth, K. & Korsmeyer, S. J. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev. 14, 23–27 (2000).

pmcid: 316347 doi: 10.1101/gad.14.1.23 pubmed: 10640272

Veis, D. J., Sorenson, C. M., Shutter, J. R. & Korsmeyer, S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229–240 (1993).

doi: 10.1016/0092-8674(93)80065-M pubmed: 8402909

Zou, H., Henzel, W. J., Liu, X., Lutschg, A. & Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405–413 (1997).

doi: 10.1016/S0092-8674(00)80501-2 pubmed: 9267021

Yuan, S. et al. The holo-apoptosome: activation of procaspase-9 and interactions with caspase-3. Structure 19, 1084–1096 (2011).

pmcid: 3155825 doi: 10.1016/j.str.2011.07.001 pubmed: 21827945

Li, Y. et al. Mechanistic insights into caspase-9 activation by the structure of the apoptosome holoenzyme. Proc. Natl Acad. Sci. USA 114, 1542–1547 (2017).

pmcid: 5320974 doi: 10.1073/pnas.1620626114 pubmed: 28143931

Julien, O. & Wells, J. A. Caspases and their substrates. Cell Death Differ. 24, 1380–1389 (2017).

pmcid: 5520456 doi: 10.1038/cdd.2017.44 pubmed: 28498362

Lakhani, S. A. et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311, 847–851 (2006).

pmcid: 3738210 doi: 10.1126/science.1115035 pubmed: 16469926

Lindsten, T. et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6, 1389–1399 (2000).

pmcid: 3057227 doi: 10.1016/S1097-2765(00)00136-2 pubmed: 11163212

Lindsten, T. & Thompson, C. B. Cell death in the absence of Bax and Bak. Cell Death Differ. 13, 1272–1276 (2006).

doi: 10.1038/sj.cdd.4401953 pubmed: 16676001

Krammer, P. H. CD95’s deadly mission in the immune system. Nature 407, 789–795 (2000).

doi: 10.1038/35037728 pubmed: 11048730

Nagata, S. Apoptosis by death factor. Cell 88, 355–365 (1997).

doi: 10.1016/S0092-8674(00)81874-7 pubmed: 9039262

Fisher, G. H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946 (1995).

doi: 10.1016/0092-8674(95)90013-6 pubmed: 7540117

Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347–1349 (1995).

doi: 10.1126/science.7539157 pubmed: 7539157

Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969–976 (1994).

doi: 10.1016/0092-8674(94)90375-1 pubmed: 7511063

Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. & Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317 (1992).

doi: 10.1038/356314a0 pubmed: 1372394

Martin, D. A. et al. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc. Natl Acad. Sci. USA 96, 4552–4557 (1999).

pmcid: 16370 doi: 10.1073/pnas.96.8.4552 pubmed: 10200300

Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181–190 (2003).

doi: 10.1016/S0092-8674(03)00521-X pubmed: 12887920

Hsu, H., Huang, J., Shu, H. B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387–396 (1996).

doi: 10.1016/S1074-7613(00)80252-6 pubmed: 8612133

Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689–700 (2008).

doi: 10.1016/j.molcel.2008.05.014 pubmed: 18570872

Mahoney, D. J. et al. Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl Acad. Sci. USA 105, 11778–11783 (2008).

pmcid: 2575330 doi: 10.1073/pnas.0711122105 pubmed: 18697935

Varfolomeev, E. et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. J. Biol. Chem. 283, 24295–24299 (2008).

pmcid: 3259840 doi: 10.1074/jbc.C800128200 pubmed: 18621737

Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831–844 (2009).

doi: 10.1016/j.molcel.2009.10.013 pubmed: 20005846

Draber, P. et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 13, 2258–2272 (2015).

pmcid: 4688036 doi: 10.1016/j.celrep.2015.11.009 pubmed: 26670046

Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 11, 123–132 (2009).

doi: 10.1038/ncb1821 pubmed: 19136968

Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–351 (2001).

doi: 10.1038/35085597 pubmed: 11460167

Ea, C. K., Deng, L., Xia, Z. P., Pineda, G. & Chen, Z. J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245–257 (2006).

doi: 10.1016/j.molcel.2006.03.026 pubmed: 16603398

Geng, J. et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat. Commun. 8, 359 (2017).

pmcid: 5572456 doi: 10.1038/s41467-017-00406-w pubmed: 28842570

Daniel, S. et al. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood 104, 2376–2384 (2004).

doi: 10.1182/blood-2003-02-0635 pubmed: 15251990

Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694–699 (2004).

doi: 10.1038/nature02794 pubmed: 15258597

He, K. L. & Ting, A. T. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol. Cell Biol. 22, 6034–6045 (2002).

pmcid: 133997 doi: 10.1128/MCB.22.17.6034-6045.2002 pubmed: 12167698

Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K. & Tschopp, J. NF-κB signals induce the expression of c-FLIP. Mol. Cell Biol. 21, 5299–5305 (2001).

pmcid: 87253 doi: 10.1128/MCB.21.16.5299-5305.2001 pubmed: 11463813

Kataoka, T. The caspase-8 modulator c-FLIP. Crit. Rev. Immunol. 25, 31–58 (2005).

doi: 10.1615/CritRevImmunol.v25.i1.30 pubmed: 15833082

Degterev, A. et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313–321 (2008).

pmcid: 5434866 doi: 10.1038/nchembio.83 pubmed: 18408713

Ofengeim, D. et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 10, 1836–1849 (2015).

pmcid: 4494996 doi: 10.1016/j.celrep.2015.02.051 pubmed: 25801023

Newton, K. et al. RIPK1 inhibits ZBP1-driven necroptosis during development. Nature 540, 129–133 (2016).

doi: 10.1038/nature20559 pubmed: 27819682

Zhang, X. et al. Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis. Nat. Commun. 10, 4158 (2019).

pmcid: 6744433 doi: 10.1038/s41467-019-11839-w pubmed: 31519886

Xu, D. et al. TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell 174, 1477–1491.e19 (2018).

pmcid: 6128749 doi: 10.1016/j.cell.2018.07.041 pubmed: 30146158

Dondelinger, Y. et al. NF-κB-independent role of IKKα/IKKβ in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol. Cell 60, 63–76 (2015).

doi: 10.1016/j.molcel.2015.07.032 pubmed: 26344099

Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591–596 (2011).

doi: 10.1038/nature09816 pubmed: 21455173

Wang, L., Du, F. & Wang, X. TNF-α induces two distinct caspase-8 activation pathways. Cell 133, 693–703 (2008).

doi: 10.1016/j.cell.2008.03.036 pubmed: 18485876

Jaco, I. et al. MK2 phosphorylates RIPK1 to prevent TNF-induced cell death. Mol. Cell 66, 698–710.e5 (2017).

pmcid: 5459754 doi: 10.1016/j.molcel.2017.05.003 pubmed: 28506461

Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112–119 (2005). Refs 48 and 57 provided the first evidence for the existence of necroptosis and the role of RIPK1 in mediating necroptosis by isolating Nec1, which was the first small-molecule RIPK1 inhibitor.

doi: 10.1038/nchembio711 pubmed: 16408008

Shan, B., Pan, H., Najafov, A. & Yuan, J. Necroptosis in development and diseases. Genes Dev. 32, 327–340 (2018).

pmcid: 5900707 doi: 10.1101/gad.312561.118 pubmed: 29593066

Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112–1123 (2009).

pmcid: 2727676 doi: 10.1016/j.cell.2009.05.037 pubmed: 19524513

He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 137, 1100–1111 (2009).

doi: 10.1016/j.cell.2009.05.021 pubmed: 19524512

Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332–336 (2009).

doi: 10.1126/science.1172308 pubmed: 19498109

Wu, J. et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 23, 994–1006 (2013).

pmcid: 3731568 doi: 10.1038/cr.2013.91 pubmed: 23835476

Degterev, A., Maki, J. L. & Yuan, J. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ. 20, 366 (2013).

doi: 10.1038/cdd.2012.133 pubmed: 23197295

Peltzer, N., Darding, M. & Walczak, H. Holding RIPK1 on the ubiquitin leash in TNFR1 signaling. Trends Cell Biol. 26, 445–461 (2016).

doi: 10.1016/j.tcb.2016.01.006 pubmed: 26877205

Li, X. et al. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat. Commun. 11, 6364 (2020).

pmcid: 7733462 doi: 10.1038/s41467-020-19935-y pubmed: 33311474

Ito, Y. et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353, 603–608 (2016).

pmcid: 5444917 doi: 10.1126/science.aaf6803 pubmed: 27493188

Dziedzic, S. A. et al. ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC. Nat. Cell Biol. 20, 58–68 (2018).

doi: 10.1038/s41556-017-0003-1 pubmed: 29203883

Vlantis, K. et al. NEMO prevents RIP kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-κB-dependent and -independent functions. Immunity 44, 553–567 (2016).

pmcid: 4803910 doi: 10.1016/j.immuni.2016.02.020 pubmed: 26982364

Meng, H. et al. Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis. Proc. Natl Acad. Sci. USA 115, E2001–E2009 (2018).

pmcid: 5834731 doi: 10.1073/pnas.1722013115 pubmed: 29440439

Lin, Y., Devin, A., Rodriguez, Y. & Liu, Z. G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13, 2514–2526 (1999).

pmcid: 317073 doi: 10.1101/gad.13.19.2514 pubmed: 10521396

Tao, P. et al. A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature 577, 109–114 (2020).

doi: 10.1038/s41586-019-1830-y pubmed: 31827280

Lalaoui, N. et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature 577, 103–108 (2020).

doi: 10.1038/s41586-019-1828-5 pubmed: 31827281

Li, J. et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150, 339–350 (2012).

pmcid: 3664196 doi: 10.1016/j.cell.2012.06.019 pubmed: 22817896

Wu, X. et al. The structure of a minimum amyloid fibril core formed by necroptosis-mediating RHIM of human RIPK3. Proc. Natl Acad. Sci. USA 118, e2022933118 (2021).

pmcid: 8040640 doi: 10.1073/pnas.2022933118 pubmed: 33790016

Chen, W. et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J. Biol. Chem. 288, 16247–16261 (2013).

pmcid: 3675564 doi: 10.1074/jbc.M112.435545 pubmed: 23612963

Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213–227 (2012). Refs 59, 60, 61 and 76 provided evidence for the roles of RIPK3 and MLKL in mediating necroptosis.

doi: 10.1016/j.cell.2011.11.031 pubmed: 22265413

Murphy, J. M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443–453 (2013).

doi: 10.1016/j.immuni.2013.06.018 pubmed: 24012422

Hildebrand, J. M. et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc. Natl Acad. Sci. USA 111, 15072–15077 (2014).

pmcid: 4210347 doi: 10.1073/pnas.1408987111 pubmed: 25288762

Polykratis, A. et al. Cutting edge: RIPK1 kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J. Immunol. 193, 1539–1543 (2014).

doi: 10.4049/jimmunol.1400590 pubmed: 25015821

Berger, S. B. et al. Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J. Immunol. 192, 5476–5480 (2014).

doi: 10.4049/jimmunol.1400499 pubmed: 24821972

Laurien, L. et al. Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation. Nat. Commun. 11, 1747 (2020).

pmcid: 7142081 doi: 10.1038/s41467-020-15466-8 pubmed: 32269263

Blanchett, S., Dondelinger, Y., Barbarulo, A., Bertrand, M. J. M. & Seddon, B. Phosphorylation of RIPK1 serine 25 mediates IKK dependent control of extrinsic cell death in T cells. Front. Immunol. 13, 1067164 (2022).

pmcid: 9756376 doi: 10.3389/fimmu.2022.1067164 pubmed: 36532075

Dondelinger, Y. et al. Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation. Nat. Commun. 10, 1729 (2019).

pmcid: 6465317 doi: 10.1038/s41467-019-09690-0 pubmed: 30988283

Zelic, M. et al. RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndrome. J. Clin. Invest. 128, 2064–2075 (2018).

pmcid: 5919800 doi: 10.1172/JCI96147 pubmed: 29664014

Zhang, T. et al. Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. Science 380, 1372–1380 (2023).

pmcid: 10617018 doi: 10.1126/science.abn1725 pubmed: 37384704

Sun, W. et al. Small molecule activators of TAK1 promotes its activity-dependent ubiquitination and TRAIL-mediated tumor cell death. Proc. Natl Acad. Sci. USA 120, e2308079120 (2023).

doi: 10.1073/pnas.2308079120 pubmed: 37733743

Kang, K., Park, C. & Chan, F. K. Necroptosis at a glance. J. Cell Sci. 135, jcs260091 (2022).

pmcid: 10658918 doi: 10.1242/jcs.260091 pubmed: 36098620

Balachandran, S. & Mocarski, E. S. Viral Z-RNA triggers ZBP1-dependent cell death. Curr. Opin. Virol. 51, 134–140 (2021).

pmcid: 8643332 doi: 10.1016/j.coviro.2021.10.004 pubmed: 34688984

He, S., Liang, Y., Shao, F. & Wang, X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl Acad. Sci. USA 108, 20054–20059 (2011).

pmcid: 3250173 doi: 10.1073/pnas.1116302108 pubmed: 22123964

Riebeling, T., Kunzendorf, U. & Krautwald, S. The role of RHIM in necroptosis. Biochem. Soc. Trans. 50, 1197–1205 (2022).

pmcid: 9444067 doi: 10.1042/BST20220535 pubmed: 36040212

Jiao, H. et al. Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation. Nature 580, 391–395 (2020).

pmcid: 7279955 doi: 10.1038/s41586-020-2129-8 pubmed: 32296175

Ingram, J. P. et al. ZBP1/DAI drives RIPK3-mediated cell death induced by IFNs in the absence of RIPK1. J. Immunol. 203, 1348–1355 (2019).

doi: 10.4049/jimmunol.1900216 pubmed: 31358656

Zhang, T. et al. Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation. Nat. Cell Biol. 25, 950–962 (2023).

pmcid: 10617019 doi: 10.1038/s41556-023-01170-4 pubmed: 37400498

Hardie, D. G. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 8, 774–785 (2007).

doi: 10.1038/nrm2249 pubmed: 17712357

Ohh, M. et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423–427 (2000).

doi: 10.1038/35017054 pubmed: 10878807

Naito, M. G. et al. Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke. Proc. Natl Acad. Sci. USA 117, 4959–4970 (2020).

pmcid: 7060720 doi: 10.1073/pnas.1916427117 pubmed: 32071228

Linkermann, A. et al. Necroptosis in immunity and ischemia-reperfusion injury. Am. J. Transpl. 13, 2797–2804 (2013).

doi: 10.1111/ajt.12448

Jouan-Lanhouet, S. et al. Necroptosis, in vivo detection in experimental disease models. Semin. Cell Dev. Biol. 35, 2–13 (2014).

doi: 10.1016/j.semcdb.2014.08.010 pubmed: 25160988

Degterev, A., Boyce, M. & Yuan, J. A decade of caspases. Oncogene 22, 8543–8567 (2003).

doi: 10.1038/sj.onc.1207107 pubmed: 14634618

Yuan, J., Najafov, A. & Py, B. F. Roles of caspases in necrotic cell death. Cell 167, 1693–1704 (2016).

pmcid: 5381727 doi: 10.1016/j.cell.2016.11.047 pubmed: 27984721

Newton, K., Dixit, V. M. & Kayagaki, N. Dying cells fan the flames of inflammation. Science 374, 1076–1080 (2021).

doi: 10.1126/science.abi5934 pubmed: 34822265

Rathinam, V. A. K., Zhao, Y. & Shao, F. Innate immunity to intracellular LPS. Nat. Immunol. 20, 527–533 (2019).

pmcid: 7668400 doi: 10.1038/s41590-019-0368-3 pubmed: 30962589

Wang, S. et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501–509 (1998).

doi: 10.1016/S0092-8674(00)80943-5 pubmed: 9491891

Kang, S. J. et al. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J. Cell Biol. 149, 613–622 (2000).

pmcid: 2174843 doi: 10.1083/jcb.149.3.613 pubmed: 10791975

de Zoete, M. R., Palm, N. W., Zhu, S. & Flavell, R. A. Inflammasomes. Cold Spring Harb. Perspect. Biol. 6, a016287 (2014).

pmcid: 4292152 doi: 10.1101/cshperspect.a016287 pubmed: 25324215

Broz, P., Pelegrin, P. & Shao, F. The gasdermins, a protein family executing cell death and inflammation. Nat. Rev. Immunol. 20, 143–157 (2020).

doi: 10.1038/s41577-019-0228-2 pubmed: 31690840

Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666–671 (2015).

doi: 10.1038/nature15541 pubmed: 26375259

Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665 (2015).

doi: 10.1038/nature15514 pubmed: 26375003

Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111–116 (2016).

doi: 10.1038/nature18590 pubmed: 27281216

Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153–158 (2016). Refs 107, 108, 109 and 110 demonstrated the role of caspase-1 and caspase-11 in the cleavage of GSDMD to promote necroptosis and the structural basis of GSDMD-NT pore formation.

pmcid: 5539988 doi: 10.1038/nature18629 pubmed: 27383986

Xia, S. et al. Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature 593, 607–611 (2021).

pmcid: 8588876 doi: 10.1038/s41586-021-03478-3 pubmed: 33883744

He, W. T. et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 25, 1285–1298 (2015).

pmcid: 4670995 doi: 10.1038/cr.2015.139 pubmed: 26611636

Moonen, S. et al. Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 145, 175–195 (2023).

doi: 10.1007/s00401-022-02528-y pubmed: 36481964

LaRock, D. L. et al. Group A Streptococcus induces GSDMA-dependent pyroptosis in keratinocytes. Nature 605, 527–531 (2022).

pmcid: 9186297 doi: 10.1038/s41586-022-04717-x pubmed: 35545676

Hansen, J. M. et al. Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions. Cell 184, 3178–3191.e18 (2021).

pmcid: 8221529 doi: 10.1016/j.cell.2021.04.036 pubmed: 34022140

Johnson, A. G. et al. Bacterial gasdermins reveal an ancient mechanism of cell death. Science 375, 221–225 (2022).

pmcid: 9134750 doi: 10.1126/science.abj8432 pubmed: 35025633

Sangiuliano, B., Perez, N. M., Moreira, D. F. & Belizario, J. E. Cell death-associated molecular-pattern molecules: inflammatory signaling and control. Mediators Inflamm. 2014, 821043 (2014).

pmcid: 4130149 doi: 10.1155/2014/821043 pubmed: 25140116

Nagata, S. Apoptosis and clearance of apoptotic cells. Annu. Rev. Immunol. 36, 489–517 (2018).

doi: 10.1146/annurev-immunol-042617-053010 pubmed: 29400998

deCathelineau, A. M. & Henson, P. M. The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem. 39, 105–117 (2003).

doi: 10.1042/bse0390105 pubmed: 14585077

Nagata, S. & Segawa, K. Sensing and clearance of apoptotic cells. Curr. Opin. Immunol. 68, 1–8 (2021).

doi: 10.1016/j.coi.2020.07.007 pubmed: 32853880

Segawa, K. et al. Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science 344, 1164–1168 (2014).

doi: 10.1126/science.1252809 pubmed: 24904167

Suzuki, J., Denning, D. P., Imanishi, E., Horvitz, H. R. & Nagata, S. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science 341, 403–406 (2013). Refs 121 and 122 described the mechanism by which caspase mediates the cleavage of phospholipid flippase to promote phosphatidylserine exposure on apoptotic cells in efferocytosis.

doi: 10.1126/science.1236758 pubmed: 23845944

Lu, J. et al. Efficient engulfment of necroptotic and pyroptotic cells by nonprofessional and professional phagocytes. Cell Discov. 5, 39 (2019).

pmcid: 6796833 doi: 10.1038/s41421-019-0108-8 pubmed: 31632688

Zargarian, S. et al. Phosphatidylserine externalization, “necroptotic bodies” release, and phagocytosis during necroptosis. PLoS Biol. 15, e2002711 (2017).

pmcid: 5501695 doi: 10.1371/journal.pbio.2002711 pubmed: 28650960

Kayagaki, N. et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 591, 131–136 (2021).

doi: 10.1038/s41586-021-03218-7 pubmed: 33472215

Degen, M. et al. Structural basis of NINJ1-mediated plasma membrane rupture in cell death. Nature 618, 1065–1071 (2023). Refs 125 and 126 report on the role of NINJ1 in mediating membrane disrupture after cell death and the structure of NINJ1.

pmcid: 10307626 doi: 10.1038/s41586-023-05991-z pubmed: 37198476

Kayagaki, N. et al. Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury. Nature 618, 1072–1077 (2023).

pmcid: 10307625 doi: 10.1038/s41586-023-06191-5 pubmed: 37196676

Le, H. et al. Disruption of ninjurin1 leads to repetitive and anxiety-like behaviors in mice. Mol. Neurobiol. 54, 7353–7368 (2017).

doi: 10.1007/s12035-016-0207-6 pubmed: 27815839

Liu, K., Wang, Y. & Li, H. The role of ninjurin1 and its impact beyond the nervous system. Dev. Neurosci. 42, 159–169 (2020).

doi: 10.1159/000512222 pubmed: 33657559

Tomita, Y. et al. Ninjurin 1 mediates peripheral nerve regeneration through Schwann cell maturation of NG2-positive cells. Biochem. Biophys. Res. Commun. 519, 462–468 (2019).

doi: 10.1016/j.bbrc.2019.09.007 pubmed: 31526566

Ifergan, I. et al. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions. Ann. Neurol. 70, 751–763 (2011).

doi: 10.1002/ana.22519 pubmed: 22162058

Lee, H. J., Ahn, B. J., Shin, M. W., Choi, J. H. & Kim, K. W. Ninjurin1: a potential adhesion molecule and its role in inflammation and tissue remodeling. Mol. Cell 29, 223–227 (2010).

doi: 10.1007/s10059-010-0043-x

Lee, H. K., Lee, H., Luo, L. & Lee, J. K. Induction of nerve injury-induced protein 1 (ninjurin 1) in myeloid cells in rat brain after transient focal cerebral ischemia. Exp. Neurobiol. 25, 64–74 (2016).

pmcid: 4844564 doi: 10.5607/en.2016.25.2.64 pubmed: 27122992

Ahn, B. J. et al. Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics. J. Biol. Chem. 289, 21926–21936 (2014).

pmcid: 4139210 doi: 10.1074/jbc.M113.532358 pubmed: 24917672

Dondelinger, Y., Hulpiau, P., Saeys, Y., Bertrand, M. J. M. & Vandenabeele, P. An evolutionary perspective on the necroptotic pathway. Trends Cell Biol. 26, 721–732 (2016).

doi: 10.1016/j.tcb.2016.06.004 pubmed: 27368376

Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000–2003 (1995).

doi: 10.1126/science.7535475 pubmed: 7535475

Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297–303 (1998).

doi: 10.1016/S1074-7613(00)80535-X pubmed: 9529147

Newton, K. et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 23, 1565–1576 (2016).

pmcid: 5072432 doi: 10.1038/cdd.2016.46 pubmed: 27177019

Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368–372 (2011).

pmcid: 3060292 doi: 10.1038/nature09857 pubmed: 21368762

Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363–367 (2011).

pmcid: 3077893 doi: 10.1038/nature09852 pubmed: 21368763

Liu, Y., Li, X., Zhou, X., Wang, J. & Ao, X. FADD as a key molecular player in cancer progression. Mol. Med. 28, 132 (2022).

pmcid: 9644706 doi: 10.1186/s10020-022-00560-y pubmed: 36348274

Najafov, A., Chen, H. & Yuan, J. Necroptosis and cancer. Trends Cancer 3, 294–301 (2017).

pmcid: 5402749 doi: 10.1016/j.trecan.2017.03.002 pubmed: 28451648

Koo, G. B. et al. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 25, 707–725 (2015).

pmcid: 4456623 doi: 10.1038/cr.2015.56 pubmed: 25952668

Najafov, A. et al. BRAF and AXL oncogenes drive RIPK3 expression loss in cancer. PLoS Biol. 16, e2005756 (2018).

pmcid: 6114281 doi: 10.1371/journal.pbio.2005756 pubmed: 30157175

Schweichel, J. U. & Merker, H. J. The morphology of various types of cell death in prenatal tissues. Teratology 7, 253–266 (1973).

doi: 10.1002/tera.1420070306 pubmed: 4807128

Anding, A. L. & Baehrecke, E. H. Autophagy in cell life and cell death. Curr. Top. Dev. Biol. 114, 67–91 (2015).

doi: 10.1016/bs.ctdb.2015.07.012 pubmed: 26431564

Levine, B. & Yuan, J. Autophagy in cell death: an innocent convict? J. Clin. Invest. 115, 2679–2688 (2005).

pmcid: 1236698 doi: 10.1172/JCI26390 pubmed: 16200202

Tsukada, M. & Ohsumi, Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett. 333, 169–174 (1993).

doi: 10.1016/0014-5793(93)80398-E pubmed: 8224160

White, E. Autophagic cell death unraveled: pharmacological inhibition of apoptosis and autophagy enables necrosis. Autophagy 4, 399–401 (2008).

doi: 10.4161/auto.5907 pubmed: 18367872

Fleming, A. et al. The different autophagy degradation pathways and neurodegeneration. Neuron 110, 935–966 (2022).

pmcid: 8930707 doi: 10.1016/j.neuron.2022.01.017 pubmed: 35134347

Menzies, F. M. et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93, 1015–1034 (2017).

doi: 10.1016/j.neuron.2017.01.022 pubmed: 28279350

de Duve, C. et al. Commentary. Lysosomotropic agents. Biochem. Pharmacol. 23, 2495–2531 (1974).

doi: 10.1016/0006-2952(74)90174-9 pubmed: 4606365

Xie, Z. et al. Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways. Cell Death Dis. 14, 255 (2023).

pmcid: 10082344 doi: 10.1038/s41419-023-05786-0 pubmed: 37031185

Vitner, E. B. et al. RIPK3 as a potential therapeutic target for Gaucher’s disease. Nat. Med. 20, 204–208 (2014).

doi: 10.1038/nm.3449 pubmed: 24441827

Liu, S. et al. Lysosomal damage after spinal cord injury causes accumulation of RIPK1 and RIPK3 proteins and potentiation of necroptosis. Cell Death Dis. 9, 476 (2018).

pmcid: 5913300 doi: 10.1038/s41419-018-0469-1 pubmed: 29686269

Pan, C. et al. Lipofuscin causes atypical necroptosis through lysosomal membrane permeabilization. Proc. Natl Acad. Sci. USA 118, e2100122118 (2021).

pmcid: 8617501 doi: 10.1073/pnas.2100122118 pubmed: 34782457

Ryckman, A. E., Brockhausen, I. & Walia, J. S. Metabolism of glycosphingolipids and their role in the pathophysiology of lysosomal storage disorders. Int. J. Mol. Sci. 21, 6881 (2020).

pmcid: 7555265 doi: 10.3390/ijms21186881 pubmed: 32961778

Yanez, M. J. et al. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: opportunities for shared therapeutic interventions. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165875 (2020).

doi: 10.1016/j.bbadis.2020.165875 pubmed: 32522631

White, E. Entosis: it’s a cell-eat-cell world. Cell 131, 840–842 (2007).

pmcid: 2857714 doi: 10.1016/j.cell.2007.11.015 pubmed: 18045529

Zeng, C., Zeng, B., Dong, C., Liu, J. & Xing, F. Rho-ROCK signaling mediates entotic cell death in tumor. Cell Death Discov. 6, 4 (2020).

pmcid: 7026421 doi: 10.1038/s41420-020-0238-7 pubmed: 32123580

Florey, O., Kim, S. E., Sandoval, C. P., Haynes, C. M. & Overholtzer, M. Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes. Nat. Cell Biol. 13, 1335–1343 (2011).

pmcid: 3223412 doi: 10.1038/ncb2363 pubmed: 22002674

Rich, K. A., Burkett, C. & Webster, P. Cytoplasmic bacteria can be targets for autophagy. Cell Microbiol. 5, 455–468 (2003).

doi: 10.1046/j.1462-5822.2003.00292.x pubmed: 12814436

Nakagawa, I. et al. Autophagy defends cells against invading group A Streptococcus. Science 306, 1037–1040 (2004).

doi: 10.1126/science.1103966 pubmed: 15528445

Ogawa, M. et al. Escape of intracellular Shigella from autophagy. Science 307, 727–731 (2005).

doi: 10.1126/science.1106036 pubmed: 15576571

Hamann, J. C. et al. Entosis is induced by glucose starvation. Cell Rep. 20, 201–210 (2017).

pmcid: 5559205 doi: 10.1016/j.celrep.2017.06.037 pubmed: 28683313

Bozkurt, E. et al. TRAIL signaling promotes entosis in colorectal cancer. J. Cell Biol. 220, e202010030 (2021).

pmcid: 8563286 doi: 10.1083/jcb.202010030 pubmed: 34546352

Yang, W. S. & Stockwell, B. R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234–245 (2008).

pmcid: 2683762 doi: 10.1016/j.chembiol.2008.02.010 pubmed: 18355723

Trachootham, D., Lu, W., Ogasawara, M. A., Nilsa, R. D. & Huang, P. Redox regulation of cell survival. Antioxid. Redox Signal. 10, 1343–1374 (2008).

pmcid: 2932530 doi: 10.1089/ars.2007.1957 pubmed: 18522489

Sato, M. et al. The ferroptosis inducer erastin irreversibly inhibits system x

pmcid: 5772355 doi: 10.1038/s41598-018-19213-4 pubmed: 29343855

Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180–1191 (2014).

doi: 10.1038/ncb3064 pubmed: 25402683

Zhang, H., Morgan, T. E. & Forman, H. J. Age-related alteration in HNE elimination enzymes. Arch. Biochem. Biophys. 699, 108749 (2021).

doi: 10.1016/j.abb.2020.108749 pubmed: 33417945

Vazdar, K., Skulj, S., Bakaric, D., Margetic, D. & Vazdar, M. Chemistry and reactivity of 4-hydroxy-2-nonenal (HNE) in model biological systems. Mini Rev. Med. Chem. 21, 1394–1405 (2021).

doi: 10.2174/1389557521666210105110538 pubmed: 33402082

Gentile, F. et al. DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity. AIMS Genet. 4, 103–137 (2017).

pmcid: 6690246 doi: 10.3934/genet.2017.2.103 pubmed: 31435505

Ayala, A., Munoz, M. F. & Arguelles, S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014, 360438 (2014).

pmcid: 4066722 doi: 10.1155/2014/360438 pubmed: 24999379

Zheng, H., Jiang, L., Tsuduki, T., Conrad, M. & Toyokuni, S. Embryonal erythropoiesis and aging exploit ferroptosis. Redox Biol. 48, 102175 (2021).

pmcid: 8577445 doi: 10.1016/j.redox.2021.102175 pubmed: 34736120

Coyle, J. T. & Puttfarcken, P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689–695 (1993).

doi: 10.1126/science.7901908 pubmed: 7901908

Dmitriev, L. F. & Titov, V. N. Lipid peroxidation in relation to ageing and the role of endogenous aldehydes in diabetes and other age-related diseases. Ageing Res. Rev. 9, 200–210 (2010).

doi: 10.1016/j.arr.2009.09.004 pubmed: 19800421

Luczaj, W., Gegotek, A. & Skrzydlewska, E. Antioxidants and HNE in redox homeostasis. Free Radic. Biol. Med. 111, 87–101 (2017).

doi: 10.1016/j.freeradbiomed.2016.11.033 pubmed: 27888001

Lynch, D. R. & Johnson, J. Omaveloxolone: potential new agent for Friedreich ataxia. Neurodegener. Dis. Manag. 11, 91–98 (2021).

doi: 10.2217/nmt-2020-0057 pubmed: 33430645

Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693–698 (2019).

doi: 10.1038/s41586-019-1707-0 pubmed: 31634899

Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688–692 (2019).

pmcid: 6883167 doi: 10.1038/s41586-019-1705-2 pubmed: 31634900

Mishima, E. et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature 608, 778–783 (2022).

pmcid: 9402432 doi: 10.1038/s41586-022-05022-3 pubmed: 35922516

Liang, D. et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 186, 2748–2764.e22 (2023). Refs 6, 181, 182 and 183 describe the roles of xCT, GPX4, FSP1 and sex hormone-mediated control of cellular lipid peroxidation and illustrate how inactivation of cellular defence mechanisms against lipid peroxidation can lead to ferroptosis.

doi: 10.1016/j.cell.2023.05.003 pubmed: 37267948

Matak, P. et al. Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice. Proc. Natl Acad. Sci. USA 113, 3428–3435 (2016).

pmcid: 4822577 doi: 10.1073/pnas.1519473113 pubmed: 26929359

Cozzi, A. et al. Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy. Neurobiol. Dis. 37, 77–85 (2010).

doi: 10.1016/j.nbd.2009.09.009 pubmed: 19781644

Ryan, S. K. et al. Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. Nat. Neurosci. 26, 12–26 (2023).

doi: 10.1038/s41593-022-01221-3 pubmed: 36536241

Chalfie, M. & Wolinsky, E. The identification and suppression of inherited neurodegeneration in Caenorhabditis elegans. Nature 345, 410–416 (1990).

doi: 10.1038/345410a0 pubmed: 2342572

Driscoll, M. & Chalfie, M. The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature 349, 588–593 (1991).

doi: 10.1038/349588a0 pubmed: 1672038

Syntichaki, P., Xu, K., Driscoll, M. & Tavernarakis, N. Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419, 939–944 (2002).

doi: 10.1038/nature01108 pubmed: 12410314

Bianchi, L. et al. The neurotoxic MEC-4(d) DEG/ENaC sodium channel conducts calcium: implications for necrosis initiation. Nat. Neurosci. 7, 1337–1344 (2004).

doi: 10.1038/nn1347 pubmed: 15543143

Hardingham, G. E., Fukunaga, Y. & Bading, H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405–414 (2002).

doi: 10.1038/nn835 pubmed: 11953750

Hernandez, D. E. et al. Axonal degeneration induced by glutamate excitotoxicity is mediated by necroptosis. J. Cell Sci. 131, jcs214684 (2018).

doi: 10.1242/jcs.214684 pubmed: 30333135

D’Orsi, B. et al. Bax regulates neuronal Ca

pmcid: 6795257 doi: 10.1523/JNEUROSCI.2453-14.2015 pubmed: 25632145

Mahmoud, S., Gharagozloo, M., Simard, C. & Gris, D. Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release. Cells 8, 184 (2019).

pmcid: 6406900 doi: 10.3390/cells8020184 pubmed: 30791579

Dawson, T. M. & Dawson, V. L. Nitric oxide signaling in neurodegeneration and cell death. Adv. Pharmacol. 82, 57–83 (2018).

doi: 10.1016/bs.apha.2017.09.003 pubmed: 29413528

Wang, Y. & Golledge, J. Neuronal nitric oxide synthase and sympathetic nerve activity in neurovascular and metabolic systems. Curr. Neurovasc. Res. 10, 81–89 (2013).

doi: 10.2174/156720213804805963 pubmed: 23151079

Steinert, J. R., Chernova, T. & Forsythe, I. D. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 16, 435–452 (2010).

doi: 10.1177/1073858410366481 pubmed: 20817920

Ghatak, S., Nakamura, T. & Lipton, S. A. Aberrant protein S-nitrosylation contributes to hyperexcitability-induced synaptic damage in Alzheimer’s disease: mechanistic insights and potential therapies. Front. Neural Circuits 17, 1099467 (2023).

pmcid: 9932935 doi: 10.3389/fncir.2023.1099467 pubmed: 36817649

Vakifahmetoglu, H., Olsson, M. & Zhivotovsky, B. Death through a tragedy: mitotic catastrophe. Cell Death Differ. 15, 1153–1162 (2008).

doi: 10.1038/cdd.2008.47 pubmed: 18404154

Castedo, M. et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825–2837 (2004).

doi: 10.1038/sj.onc.1207528 pubmed: 15077146

Castedo, M. et al. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 23, 4362–4370 (2004).

doi: 10.1038/sj.onc.1207572 pubmed: 15048075

Brinkmann, K., Ng, A. P., de Graaf, C. A. & Strasser, A. What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy? Cell Death Differ. 29, 1079–1093 (2022).

pmcid: 9177562 doi: 10.1038/s41418-022-00987-0 pubmed: 35388168

Smith, W. M. & Reed, D. R. Targeting apoptosis in ALL. Curr. Hematol. Malig. Rep. 17, 53–60 (2022).

doi: 10.1007/s11899-022-00661-9 pubmed: 35538391

Mifflin, L., Ofengeim, D. & Yuan, J. Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat. Rev. Drug Discov. 19, 553–571 (2020).

pmcid: 7362612 doi: 10.1038/s41573-020-0071-y pubmed: 32669658

Ofengeim, D. et al. RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease. Proc. Natl Acad. Sci. USA 114, E8788–E8797 (2017).

pmcid: 5642727 doi: 10.1073/pnas.1714175114 pubmed: 28904096

Zelic, M. et al. RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis. Cell Rep. 35, 109112 (2021).

pmcid: 8917516 doi: 10.1016/j.celrep.2021.109112 pubmed: 33979622

Li, W. et al. Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response. Cell Res. 32, 621–637 (2022).

pmcid: 9253060 doi: 10.1038/s41422-022-00673-3 pubmed: 35661830

Li, W. & Yuan, J. Targeting RIPK1 kinase for modulating inflammation in human diseases. Front. Immunol. 14, 1159743 (2023).

pmcid: 10030951 doi: 10.3389/fimmu.2023.1159743 pubmed: 36969188

Rathinam, V. A. & Fitzgerald, K. A. Inflammasome complexes: emerging mechanisms and effector functions. Cell 165, 792–800 (2016).

pmcid: 5503689 doi: 10.1016/j.cell.2016.03.046 pubmed: 27153493

Zhan, X., Li, Q., Xu, G., Xiao, X. & Bai, Z. The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors. Front. Immunol. 13, 1109938 (2022).

doi: 10.3389/fimmu.2022.1109938 pubmed: 36741414

Sweeney, P. et al. Protein misfolding in neurodegenerative diseases: implications and strategies. Transl. Neurodegener. 6, 6 (2017).

pmcid: 5348787 doi: 10.1186/s40035-017-0077-5 pubmed: 28293421

Xu, D. et al. Modulating TRADD to restore cellular homeostasis and inhibit apoptosis. Nature 587, 133–138 (2020).

doi: 10.1038/s41586-020-2757-z pubmed: 32968279

Sies, H. & Jones, D. P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 21, 363–383 (2020).

doi: 10.1038/s41580-020-0230-3 pubmed: 32231263

Markesbery, W. R., Kryscio, R. J., Lovell, M. A. & Morrow, J. D. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann. Neurol. 58, 730–735 (2005).

doi: 10.1002/ana.20629 pubmed: 16240347

Pratico, D., Uryu, K., Leight, S., Trojanoswki, J. Q. & Lee, V. M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183–4187 (2001).

pmcid: 6762743 doi: 10.1523/JNEUROSCI.21-12-04183.2001 pubmed: 11404403

Yuan, J. & Horvitz, H. R. A first insight into the molecular mechanisms of apoptosis. Cell 116, S53–S56 (2004).

doi: 10.1016/S0092-8674(04)00028-5 pubmed: 15055582

Thornberry, N. A. et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907–17911 (1997).

doi: 10.1074/jbc.272.29.17907 pubmed: 9218414

Cerretti, D. P. et al. Molecular cloning of the interleukin-1β converting enzyme. Science 256, 97–100 (1992).

doi: 10.1126/science.1373520 pubmed: 1373520

Thornberry, N. A. et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356, 768–774 (1992).

doi: 10.1038/356768a0 pubmed: 1574116

Horvitz, H. R., Shaham, S. & Hengartner, M. O. The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb. Symp. Quant. Biol. 59, 377–385 (1994).

doi: 10.1101/SQB.1994.059.01.042 pubmed: 7587090

Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A. & Yuan, J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653–660 (1993).

doi: 10.1016/0092-8674(93)90486-A pubmed: 8242741

Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M. & Horvitz, H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75, 641–652 (1993).

doi: 10.1016/0092-8674(93)90485-9 pubmed: 8242740

Cory, S., Roberts, A. W., Colman, P. M. & Adams, J. M. Targeting BCL-2-like proteins to kill cancer cells. Trends Cancer 2, 443–460 (2016).

doi: 10.1016/j.trecan.2016.07.001 pubmed: 28741496

Nakamura, T. et al. Phase separation of FSP1 promotes ferroptosis. Nature 619, 371–377 (2023).

pmcid: 10338336 doi: 10.1038/s41586-023-06255-6 pubmed: 37380771

Ryan, S. K. et al. Therapeutic inhibition of ferroptosis in neurodegenerative disease. Trends Pharmacol. Sci. 44, 674–688 (2023).

doi: 10.1016/j.tips.2023.07.007 pubmed: 37657967

Tonnus, W. et al. Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury. Nat. Commun. 12, 4402 (2021).

pmcid: 8292346 doi: 10.1038/s41467-021-24712-6 pubmed: 34285231

Singh, J., Habean, M. L. & Panicker, N. Inflammasome assembly in neurodegenerative diseases. Trends Neurosci. 65, 885–904 (2023).

Fetter, T., de Graaf, D. M., Claus, I. & Wenzel, J. Aberrant inflammasome activation as a driving force of human autoimmune skin disease. Front. Immunol. 14, 1190388 (2023).

pmcid: 10266227 doi: 10.3389/fimmu.2023.1190388 pubmed: 37325658

Vontell, R. T. et al. Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer’s disease. Brain Pathol. 33, e13142 (2023).

doi: 10.1111/bpa.13142 pubmed: 36579934

Parmar, D. V. et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1: first-in-human phase 1 studies (single ascending dose and multiple ascending dose). Clin. Pharmacol. Drug Dev. 12, 202–211 (2023).

doi: 10.1002/cpdd.1162 pubmed: 36065092

Ambrus-Aikelin, G. et al. JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders. Sci. Rep. 13, 13524 (2023).

pmcid: 10439952 doi: 10.1038/s41598-023-39805-z pubmed: 37598239

Xie, T. et al. Structural basis of RIP1 inhibition by necrostatins. Structure 21, 493–499 (2013).

doi: 10.1016/j.str.2013.01.016 pubmed: 23473668

Chen, L. et al. Advances in RIPK1 kinase inhibitors. Front. Pharmacol. 13, 976435 (2022).

pmcid: 9554302 doi: 10.3389/fphar.2022.976435 pubmed: 36249746

Feng, X. et al. Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer. Neoplasma 62, 592–601 (2015).

doi: 10.4149/neo_2015_071 pubmed: 25997957

Yan, J., Wan, P., Choksi, S. & Liu, Z. G. Necroptosis and tumor progression. Trends Cancer 8, 21–27 (2022).

doi: 10.1016/j.trecan.2021.09.003 pubmed: 34627742

Seifert, L. et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature 532, 245–249 (2016).

pmcid: 4833566 doi: 10.1038/nature17403 pubmed: 27049944

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Junying Yuan (J)

Dimitry Ofengeim (D)

Classifications MeSH